The rise of artificial intelligence (AI), machine learning (ML), and other digital health technologies holds great potential for transforming healthcare delivery and speeding up the development of new medical products. This includes both pharmaceuticals and medical devices. As these advanced technologies are being increasingly used in the medical field, the US Food and Drug Administration (FDA) has been proactive in updating its regulatory policies to keep pace.
In an upcoming webinar, we will delve into how the FDA regulates digital health technologies, especially AI/ML, designed for health-related purposes. We will also explore recent FDA developments related to AI/ML and the FDA’s stance on utilizing AI/ML in pharmaceutical and medical device research and development activities.
CLE credit is currently pending approval in multiple states including CA, IL, NY, PA, TX, VA, and WA with reciprocity available for CT, FL, and NJ. Join us for this insightful webinar to stay informed on the latest FDA regulations and policies concerning digital health technologies.